Mirum Pharmaceuticals Presents Long-Term LIVMARLI® (maralixibat) Data and New Alagille Syndrome Caregiver Burden Analysis at NASPGHAN 2022 Annual Meeting


– Six-year natural history comparison with maralixibat demonstrates event-free and transplant-free survival in patients with Alagille syndrome (ALGS) – Characterization of four-year growth improvement in Alagille syndrome with maralixibat – New analysis evaluating health-related quality of life impact assessed on caregivers of children with Alagille syndrome – Mirum to host a scientific symposium on the…

Read More

Recorded Webinar: Accelerating Trials Through Innovative Clinical Trial Designs


On May 25th, 2021 TrialStat’s very own Christopher Kata, and Heather Williams hosted an incredible webinar with our guest Speaker John Amrhein, VP of McDougall Scientific. John presented his perspective on “Accelerating Trials Through Innovative Clinical Trial Designs” and taking questions from our live audience! Download the Slide Deck, and Watch The Webinar Recording On…

Read More

Webinar – Safer Technologies Program: Final Guidance


Summary: On Monday, February 1, 2021, the FDA will host a webinar on the Safer Technologies Program for industry and other stakeholders interested in learning more about the Program and final guidance. Background: The U.S. Food and Drug Administration (FDA) issued a final guidance outlining the Safer Technologies Program for Medical Devices. This program is a…

Read More